MONOAMINE NEUROTRANSMITTERS AND THEIR METABOLITES IN BRAIN-REGIONS IN ALZHEIMERS-DISEASE - A POSTMORTEM STUDY

被引:100
作者
NAZARALI, AJ [1 ]
REYNOLDS, GP [1 ]
机构
[1] QUEENS MED CTR,DEPT PATHOL,NOTTINGHAM NG7 2UH,ENGLAND
关键词
ALZHEIMERS DISEASE; POSTMORTEM BRAIN; NEUROTRANSMITTERS; CATECHOLAMINES; INDOLEAMINES; ACID METABOLITES;
D O I
10.1007/BF00711237
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
1. Concentrations of the neurotransmitter amines noradrenaline (NA), dopamine (DA), and 5-hydroxytryptamine (5-HT) and the acid metabolites homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were determined in four regions of postmortem brains of demented patients with or without Alzheimer's disease (AD). 2. NA was deficient in the temporal cortex (BA 21) of AD, but not of non-AD, patients. 3. Caudate, in particular, had an impaired dopaminergic system in AD patients, with low HVA levels. 4. In all regions investigated [amygdala, caudate, putamen, temporal cortex (BA 21)] 5-HT was significantly depleted in AD patients, and 5-HIAA was also depleted in amygdala and caudate. 5. These results indicate that neurotransmitter systems other than cholinergic systems are also widely affected in AD and suggest that these deficits may also play an important role in determining the symptomatology of AD.
引用
收藏
页码:581 / 587
页数:7
相关论文
共 37 条
[1]   CHANGES IN THE BRAIN CATECHOLAMINES IN PATIENTS WITH DEMENTIA OF ALZHEIMER TYPE [J].
ADOLFSSON, R ;
GOTTFRIES, CG ;
ROOS, BE ;
WINBLAD, B .
BRITISH JOURNAL OF PSYCHIATRY, 1979, 135 (SEP) :216-223
[2]  
ARAI H, 1984, J NEUROCHEM, V43, P388
[3]   BIOGENIC-AMINES AND THEIR METABOLITES IN ALZHEIMERS-DISEASE - NORADRENALINE, 5-HYDROXYTRYPTAMINE AND 5-HYDROXYINDOLE-3-ACETIC ACID DEPLETED IN HIPPOCAMPUS BUT NOT IN SUBSTANTIA INNOMINATA [J].
BAKER, GB ;
REYNOLDS, GP .
NEUROSCIENCE LETTERS, 1989, 100 (1-3) :335-339
[4]  
BONDAREFF W, 1981, LANCET, V1, P783
[5]   BIOCHEMICAL ASSESSMENT OF SEROTONERGIC AND CHOLINERGIC DYSFUNCTION AND CEREBRAL ATROPHY IN ALZHEIMERS-DISEASE [J].
BOWEN, DM ;
ALLEN, SJ ;
BENTON, JS ;
GOODHARDT, MJ ;
HAAN, EA ;
PALMER, AM ;
SIMS, NR ;
SMITH, CCT ;
SPILLANE, JA ;
ESIRI, MM ;
NEARY, D ;
SNOWDON, JS ;
WILCOCK, GK ;
DAVISON, AN .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (01) :266-272
[6]   REDUCED DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN ALZHEIMERS-DISEASE [J].
CROSS, AJ ;
CROW, TJ ;
PERRY, EK ;
PERRY, RH ;
BLESSED, G ;
TOMLINSON, BE .
BRITISH MEDICAL JOURNAL, 1981, 282 (6258) :93-94
[7]   MONOAMINE METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE [J].
CROSS, AJ ;
CROW, TJ ;
JOHNSON, JA ;
JOSEPH, MH ;
PERRY, EK ;
PERRY, RH ;
BLESSED, G ;
TOMLINSON, BE .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 60 (03) :383-392
[8]   REDUCED SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN CEREBRAL-CORTEX FROM CASES OF ALZHEIMER-DISEASE AND ALZHEIMER SENILE DEMENTIA [J].
DAVIES, P ;
KATZMAN, R ;
TERRY, RD .
NATURE, 1980, 288 (5788) :279-280
[9]  
DAVIES P, 1976, LANCET, V2, P1403
[10]  
DEJONG RN, 1975, NERVOUS SYSTEM CLINI, V2, P449